Fabrication and evaluation of a sulfacetamide-loaded niosomal gel for the treatment of ocular bacterial infections
PLOS One · 05.11.2026 · 21 (11) · e0362096
DOI: 10.1371/journal.pone.0362096 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 05.11.2026. Verfasst von Neda Sistani Karampour und 6 weiteren Autor:innen. Beteiligte Einrichtung: Marine Pharmaceutical Science Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Hauptthemen laut MEDLINE: Liposomes, Sulfacetamide, Anti-Bacterial Agents, Staphylococcal Infections. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ahvaz Jundishapur University of Medical Sciences.
Abstract (Originalsprache)
Topical ocular drug delivery is often restricted by rapid precorneal clearance, which can decrease drug residence time and bioavailability at the ocular surface. The purpose of the study was to develop a sulfacetamide-loaded niosomal gel (SA-Nio-Gel) to enhance ocular drug delivery. Thin film hydration method was used for the preparation of SA niosomes, employing nonionic surfactants (Span 60 and Span 80) and cholesterol. The optimized niosomal formulation was then incorporated into a Carbopol 934 gel base to prepare the final SA-Nio-Gel formulation. The optimized niosomes exhibited encapsulation efficiency of 76% ± 1.5 and a mean particle size of 129.7 ± 2.52 nm. Rheological analysis of the SA-Nio-Gel demonstrated pseudoplastic behavior, characterized by a reduction in viscosity with increasing shear rate. Biocompatibility evaluation indicated that the formulation was non-toxic. In vitro release profiles showed a slow and sustained SA release from the developed formulation. Furthermore, microbiological assays confirmed the potent antibacterial activity of the SA-Nio-Gel against S. aureus. Compared to the SA solution and SA-Nio, the SA-Nio-Gel formulation significantly minimized precorneal drainage and improved drug penetration. These results indicate that the niosomal gel-based system could be a promising platform for the ocular delivery of SA, which provides sustained release and enhanced drug permeability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Marine Pharmaceutical Science Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Nanotechnology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Department of Toxicology, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Medical Biomaterials Research Centre (MBRC), Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Somayeh Handali
Förderung
- Ahvaz Jundishapur University of Medical Sciences
Zitieren
APA
Sistani Karampour, N., Dolati, P., Salim, A., Abedini Baghbadorani, M., Keykhaee, M., Handali, S., & Moghimipour, E. (2026). Fabrication and evaluation of a sulfacetamide-loaded niosomal gel for the treatment of ocular bacterial infections. PLOS One, 21(11), e0362096. https://doi.org/10.1371/journal.pone.0362096
Vancouver
Sistani Karampour N, Dolati P, Salim A, Abedini Baghbadorani M, Keykhaee M, Handali S, et al. Fabrication and evaluation of a sulfacetamide-loaded niosomal gel for the treatment of ocular bacterial infections. PLOS One. 2026;21(11):e0362096. doi:10.1371/journal.pone.0362096
BibTeX
@article{SistaniKarampour2026,
author = {Sistani Karampour, Neda and Dolati, Pouya and Salim, Anayatollah and Abedini Baghbadorani, Maryam and Keykhaee, Maryam and Handali, Somayeh and Moghimipour, Eskandar},
title = {Fabrication and evaluation of a sulfacetamide-loaded niosomal gel for the treatment of ocular bacterial infections},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {11},
pages = {e0362096},
doi = {10.1371/journal.pone.0362096}
}
EUVIMED